<DOC>
	<DOCNO>NCT01455480</DOCNO>
	<brief_summary>The objective Trial evaluate performance RPh201 treatment heal partial thickness burn . It postulate deep second degree lesion benefit RPh201 treatment promote granulation epithelialization well wound closure .</brief_summary>
	<brief_title>Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn</brief_title>
	<detailed_description>The objective Trial evaluate performance RPh201 treatment partial thickness burn ( second degree superficial deep ) less 5 % TBSA . The additional follow period 20 week schedule extend evaluation wound Subjects complete 3 week treatment This include : - Efficacy assessment burn improvement follow use RPh2O1 oil solution administer topically three time per week overall treatment period 3 week follow-up visit 20 week end treatment Subjects partial thickness burn ( second degree superficial deep ) less 5 % TBSA - Safety evaluation RPh201 formulate oil solution administer topically three time per week overall treatment period 3 week Subjects partial thickness burn ( second degree superficial deep ) less 5 % TBSA .</detailed_description>
	<mesh_term>Burns</mesh_term>
	<criteria>1 . The Subject 18 year age old . 2 . The Subject least one burn wind 1 % 5 % TBSA overall . 3 . Subjects define partial thickness burn conservative treatment ( second degree superficial deep ) . 4 . Subjects eligible participate Trial target lesion area edge 500750 cm2 baseline . 5 . The Subject expect available 3 week Trial ambulatory treatment . 6 . The Subject willing able adhere protocol regimen . 7 . The Subject able read , understand , sign informed consent form . 1 . Electrical chemical burn wound third degree full thickness . 2 . Burn wound 48hours burn event 3 . Presence systemic infection significant local infection cellulite , purulent drainage , gangrene , necrosis target wound site , well nonviable tissue , sinus tract tunnel remove debridement . 4 . Previous history illness condition may impair wound healing , immune deficiency connective tissue disease ( e.g. , SLE , AIDS ) , neurological disease ( e.g. , multiple sclerosis ) , dialysis due renal disease active hepatic disease . 5 . Known history allergy cottonseed oil mastic gum 6 . Subject receiving , receive within one month prior Visit 1 treatment know impair wound healing , include limited : corticosteroid , immunosuppressive drug , cytotoxic agent , radiation therapy chemotherapy . 7 . Presence suspicion malignancy . 8 . Female Subjects pregnant nursing , childbearing potential use adequate contraception . 9 . Participation another clinical trial within 30 day prior Screening Visit Trial . 10 . Mentally disable Subjects 11 . A tourist foreigner refugee follow Trial period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Second Degree Burn</keyword>
	<keyword>partial thickness burn</keyword>
</DOC>